A newly identified role for superoxide in inflammatory pain

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 869-878

  Wang, Zhi Qiang ^a   Porreca, Frank ^b   Cuzzocrea, Salvatore ^c   Galen, Karen ^a   Lightfoot, Richard ^d   Masini, Emanuela ^e   Muscoli, Carolina ^a,f   Mollace, Vincenzo ^f   Ndengele, Michael ^a   Ischiropoulos, Harry ^d   Salvemini, Daniela ^a  

^a MetaPhore Pharmaceuticals   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CARRAGEENAN; CYTOKINE; MANGANESE SUPEROXIDE DISMUTASE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); NALOXONE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXYNITRITE; RADICAL; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; HYPERALGESIA; INFLAMMATION; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PAIN; PRIORITY JOURNAL; RAT;

ANIMALS; CARRAGEENAN; EDEMA; HYPERALGESIA; MALE; ORGANOMETALLIC COMPOUNDS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 2442648975     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.064154     Document Type: Article

References (40)

1. Anonymous (1995) FY 95 funding mechanisms for the national action plan on breast cancer. NIH Guide 24:1-15.
2. Aulak KS, Koeck T, Crabb JW, and Stuehr DJ (2004) Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol 286:H30-38.
3. Beauchamp C and Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44:276-287.
4. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
5. Bennett GJ (2000) Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 19:S2-S6.
6. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJ, and Moncada S (1993) The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 110:1189-1195.
7. Coderre TJ and Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670.
8. Cuzzocrea S, Zingarelli B, Costantino G, and Caputi AP (1999) Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in carrageenan-induced pleurisy. Free Radic Biol Med 26:25-33.
9. Dix TA, Hess KM, Medina MA, Sullivan RW, Tilly SL, and Webb TL (1996) Mechanism of site-selective DNA nicking by the hydrodioxyl (perhydroxyl) radical. Biochemistry 35:4578-4583.
10. Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, and Braquet P (1991) Superoxide dimutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion. Free Radic Res Comm 12:725-735.
11. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet J (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperaxidase in neutrophils. Nature (Lond) 391:393-397.
12. Elfering SL, Haynes VL, Traaseth NJ, Ettl A, and Giulivi C (2004) Aspects, mechanism and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 286:H22-29.
13. Fridovich I (1999) Fundamental aspects of reactive oxygen species, or what's the matter with oxygen. Ann N Y Acad Sci 893:13-18.
14. Fries DM, Paxinou E, Themistcleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HF, Hazen SL, and Ischiropoulos H (2003) Expression of inducible nitric oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells. J Biol Chem 278:22901-22907.
15. Gius D, Botero A, Shah S, and Curry HA (1999) Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappa B and AP-1. Toxicol Lett 106:93-106.
16. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
17. Hunskaar S and Hole K (1987) The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30:103-114.
18. Inoue S and Kawanishi S (1995) Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 371:86-88.
19. Kitto KF, Haley JE, and Wilcox GL (1992) Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 148:1-5.
20. Lafon-Cazal M, Pietri S, Culcasi M, and Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature (Lond) 364:535-537.
21. MacMillan-Crow LA and Cruthirds DL (2001) Manganese superoxide dismutase in disease. Free Radic Res 34:325-336.
22. Matata BM and Galinanes M (2002) Peroxynitrite is an essential component of cytokine production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem 277:2330-2335.
23. Mayer DJ, Mao J, Holt J, and Price DD (1999) Cellular mechanisms of neuropathic pain, morphine tolerance and their interactions. Proc Natl Acad Sci USA 96:7731-7736.
24. McCord JM and Fridovich I (1969) Superoxide dismutase: an enzymatic function for erythrocuprein. J Biol Chem 244:6049-6055.
25. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, and Salvemini D (2003) On the selectivity of the superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 140:445-460.
26. Nishida S, Teramoto K, Kimoto-Kinoshita S, Tohda Y, Nakajima S, Tomura TT, and Irimajiri K (2002) Changes of Cu,Zn-superoxide dismutase activity of guinea pig lung in experimental asthma. Free Radic Res 36:601-606.
27. Oyanagui Y (1976) Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema. Biochem Pharmacol 25:1465-1472.
28. Salvemini D, Jensen MP, Riley DP, and Misko TP (1998) Therapeutic manipulations of peroxynitrite. Drug News Perspectives 11:204-214.
29. Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, and Cuzzocrea S (2001) Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum 44:2909-2922.
30. Salvemini D, Wang ZQ, Wyatt P, Bourdon DM, Marino MH, Manning PT, and Currie MG (1996) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw. Br J Pharmacol 118:829-838.
31. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, and Riley DP (1999) A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science (Wash DC) 286:304-306.
32. Souza JM, Choi I, Chen Q, Weisse M, Daikhin E, Yudkoff M, Obin M, Ara J, Horwitz J, and Ischiropoulos H (2000) Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380:360-366.
33. Squadrito GL and Pryor WA (1995) The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact 96:203-206.
34. Szabó C and Dawson VL (1999) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287-298.
35. Urban MO and Gebhart GF (1999) Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 96:7687-7692.
36. Virag L and Szabó C (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429.
37. Wall PD and Melzack R (2000) Textbook of Pain, 4th ed, Churchill Livingstone, London.
38. Wang P and Zweier JL (1996) Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271:29223-29230.
39. Watkins LR, Milligan ED, and Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
40. Yamakura F, Taka H, Fujimura T, and Murayama K (1998) Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem 273:14085-14089.